Table 3. Population comparison according to CE-CD categories.

	CE-CD: < 9 n = 112 (35.9 %)	CE-CD: 9–13 n = 27 (8.7 %)	CE-CD: ≥ 13 n = 173 (55.4 %)	P value
CE-CD	0 (0–3)	9 (9–10)	22 (18–27)	< 0.001
PCDAI	5 (2.5–12.5)	5 (0–5)	17.5 (12–25)	< 0.001
FCP (μg/g)	90 (50–150)	150 (100–200)	550 (250–1200)	< 0.001
Hemoglobin (g/dL)	12.9 (12.5–13.5)	12.1 (11.9–12.4)	11.3 (10.8–12)	< 0.001
Serum albumin (g/dL)	4.3 (4.1–4.4)	4 (3.9–4.3)	3.7 (3.3–3.9)	< 0.001
C-reactive protein (mg/L)	1 (1–2)	2 (1–3)	8 (4–12)	< 0.001
PCDAI < 10 (n: 132)	79 (59.9 %)	18 (13.6 %)	35 (26.5 %)	< 0.001
PCDAI 10–30 (n: 155)	31 (20 %)	9 (5.8 %)	115 (74.2 %)
PCDAI > 30 (n: 25)	2 (8 %)	0 (0 %)	23 (92 %)

Data are expressed as median (P25–75) or number (percentages).

CE-CD, capsule endoscopic-Crohn’s Disease; PCDAI, Pediatric Crohn’s Disease Activity Index.